« Back to Record
Citation APA

Rodón, J., Tan, D. S. W., Garrido-Laguna, I., Harb, W. W., Bessudo, A., Beck, J. T., Rottey, S., Bahary, N., Kotecki, N., Zhu, Z., Deng, S., Kowalski, K., Wei, C., Pathan, N., Laliberte, R., & Messersmith, W. (2023). Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open, 8(4), 101584. doi:10.1016/j.esmoop.2023.101584


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/372489

Rodón, J., Tan, D. S. W., Garrido-Laguna, I., Harb, W. W., Bessudo, A., Beck, J. T., Rottey, S., Bahary, N., Kotecki, N., Zhu, Z., Deng, S., Kowalski, K., Wei, C., Pathan, N., Laliberte, R., & Messersmith, W. (2023). Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open, 8(4), 101584. doi:10.1016/j.esmoop.2023.101584